Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Sibony

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
European Journal of Endocrinology|June 14, 2025
Unexpected discrepancies between steroid intra-tissular content in adrenal tumors and clinical diagnosis of steroid excessFidéline Bonnet-Serrano, Louis Thomeret, Nesrine Benanteur, et al.
The American Journal of Surgical Pathology|March 18, 2008
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literaturePhilippe Camparo, Viorel Vasiliu, Vincent Molinie, et al.
European Journal of Endocrinology|March 10, 2022
Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinomaAnne Jouinot, Juliane Lippert, Mathilde Sibony, et al.
The American Journal of Surgical Pathology|August 9, 2017
Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct EntityKiril Trpkov, Hatem Abou-Ouf, Ondřej Hes, et al.
Molecular Carcinogenesis|September 2, 2009
Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinomaAshraf A Bakkar, Yves Allory, Yuriko Iwatsubo, et al.
Nature Communications|January 28, 2015
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Eric Letouzé, Nelly Burnichon, et al.
Plos One|December 29, 2012
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancerYann Neuzillet, Xavier Paoletti, Slah Ouerhani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2018
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluationKarine Renaudin, Sarra Smati, Matthieu Wargny, et al.
Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.
Science Translational Medicine|July 11, 2014
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotypeSandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
European Journal of Endocrinology|June 14, 2025
Unexpected discrepancies between steroid intra-tissular content in adrenal tumors and clinical diagnosis of steroid excessFidéline Bonnet-Serrano, Louis Thomeret, Nesrine Benanteur, et al.
The American Journal of Surgical Pathology|March 18, 2008
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literaturePhilippe Camparo, Viorel Vasiliu, Vincent Molinie, et al.
European Journal of Endocrinology|March 10, 2022
Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinomaAnne Jouinot, Juliane Lippert, Mathilde Sibony, et al.
The American Journal of Surgical Pathology|August 9, 2017
Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct EntityKiril Trpkov, Hatem Abou-Ouf, Ondřej Hes, et al.
Molecular Carcinogenesis|September 2, 2009
Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinomaAshraf A Bakkar, Yves Allory, Yuriko Iwatsubo, et al.
Nature Communications|January 28, 2015
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Eric Letouzé, Nelly Burnichon, et al.
Plos One|December 29, 2012
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancerYann Neuzillet, Xavier Paoletti, Slah Ouerhani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2018
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluationKarine Renaudin, Sarra Smati, Matthieu Wargny, et al.
Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.
Science Translational Medicine|July 11, 2014
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotypeSandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, et al.
Pageof 12